# Ching Zhu

> Ching Zhu is a Series B investor at 6 Dimensions Capital backing Biopharma and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [6 Dimensions Capital](https://shizune.co/investors/profile/6-dimensions-capital)
- Total investments: 2
- Last investment: Feb 2019
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/ching-zhu-%E6%9C%B1%E9%9D%92%E7%94%9F-a8a63b

Ching Zhu is a Series B investor at 6 Dimensions Capital focused on Biopharma and Health Care. Ching Zhu

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 50% |
| Health Care | 1 | 50% |
| Medical Device | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NeuSpera Medical | NeuSpera Medical develops implantable medical device technology to treat chronic illnesses through minimally invasive solutions. NeuSpera focuses on bioelectronic medicine and has developed ultra-miniaturized implants using their proprietary Mid-Field Powering technology. This technology allows the implants to be powered externally, enabling deeperand more reliable neuromodulation treatments for conditions like Urinary Urgency Incontinence (UUI) and chronic peripheral nerve pain | $12M | Series B | Feb 20, 2019 |  |
| NeuSpera Medical | NeuSpera Medical develops implantable medical device technology to treat chronic illnesses through minimally invasive solutions. NeuSpera focuses on bioelectronic medicine and has developed ultra-miniaturized implants using their proprietary Mid-Field Powering technology. This technology allows the implants to be powered externally, enabling deeperand more reliable neuromodulation treatments for conditions like Urinary Urgency Incontinence (UUI) and chronic peripheral nerve pain | $26M | Series B | Jan 24, 2018 |  |

2 of 2 investments shown.

## Co-investors
- [Action Potential Venture Capital](https://shizune.co/investors/profile/action-potential-venture-capital) — VC Fund, 2 deals together
- [Windham Venture Partners](https://shizune.co/investors/profile/windham-venture-partners) — VC Fund, 2 deals together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 1 deal together
- [Delta Capital Management](https://shizune.co/investors/profile/delta-capital-management) — VC Fund, 1 deal together

## About 6 Dimensions Capital

VC Fund · Shanghai, China

6 Dimensions Capital was established in May, 2017 through the merger of Frontline BioVentures and WuXi Healthcare Ventures. The two prominent and experienced teams formed a healthcare focused investment firm with an in-depth focus and extensive coverage both in China and global market.

5 contacts available at 6 Dimensions Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Ching Zhu | Managing Partner | https://shizune.co/investors/profile/ching-zhu |
| Dr. Ge Li | Founding Partner & Chairman | https://shizune.co/investors/profile/dr-ge-li |
| Edward Hu | Founding Partner | https://shizune.co/investors/profile/edward-hu-6a2b |
| Hannes Thor Smárason | Venture Partner | https://shizune.co/investors/profile/hannes-thor-smrason |
| Lianyong Chen | Managing Partner and CEO | https://shizune.co/investors/profile/lianyong-chen |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Ching Zhu invest in?

Ching Zhu invests primarily in Biopharma, Health Care and Medical Device startups, most often at Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Ching Zhu last invest?

The most recent investment recorded for Ching Zhu closed in Feb 2019. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co